HIGH TIDE INC (HITI) Stock Fundamental Analysis

USA Nasdaq NASDAQ:HITI • CA42981E4013

2.35 USD
+0.08 (+3.52%)
At close: Feb 6, 2026
2.38 USD
+0.03 (+1.28%)
After Hours: 2/6/2026, 8:00:01 PM
Fundamental Rating

4

HITI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. HITI has a medium profitability rating, but doesn't score so well on its financial health evaluation. HITI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year HITI has reported negative net income.
  • In the past year HITI had a positive cash flow from operations.
  • HITI had negative earnings in each of the past 5 years.
  • Of the past 5 years HITI 4 years had a positive operating cash flow.
HITI Yearly Net Income VS EBIT VS OCF VS FCFHITI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M -60M

1.2 Ratios

  • HITI has a Return On Assets of -14.54%. This is in the better half of the industry: HITI outperforms 62.83% of its industry peers.
  • HITI has a Return On Equity of -57.92%. This is comparable to the rest of the industry: HITI outperforms 48.17% of its industry peers.
  • The Return On Invested Capital of HITI (5.17%) is better than 82.72% of its industry peers.
Industry RankSector Rank
ROA -14.54%
ROE -57.92%
ROIC 5.17%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
HITI Yearly ROA, ROE, ROICHITI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • HITI has a Operating Margin of 2.74%. This is in the better half of the industry: HITI outperforms 78.01% of its industry peers.
  • HITI's Operating Margin has improved in the last couple of years.
  • HITI has a Gross Margin (25.99%) which is comparable to the rest of the industry.
  • In the last couple of years the Gross Margin of HITI has declined.
Industry RankSector Rank
OM 2.74%
PM (TTM) N/A
GM 25.99%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
HITI Yearly Profit, Operating, Gross MarginsHITI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

2

2. Health

2.1 Basic Checks

  • HITI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, HITI has more shares outstanding
  • Compared to 5 years ago, HITI has more shares outstanding
  • Compared to 1 year ago, HITI has a worse debt to assets ratio.
HITI Yearly Shares OutstandingHITI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
HITI Yearly Total Debt VS Total AssetsHITI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • HITI has an Altman-Z score of 1.60. This is a bad value and indicates that HITI is not financially healthy and even has some risk of bankruptcy.
  • HITI's Altman-Z score of 1.60 is in line compared to the rest of the industry. HITI outperforms 57.59% of its industry peers.
  • HITI has a debt to FCF ratio of 8.31. This is a slightly negative value and a sign of low solvency as HITI would need 8.31 years to pay back of all of its debts.
  • HITI has a Debt to FCF ratio of 8.31. This is amongst the best in the industry. HITI outperforms 80.63% of its industry peers.
  • HITI has a Debt/Equity ratio of 0.94. This is a neutral value indicating HITI is somewhat dependend on debt financing.
  • The Debt to Equity ratio of HITI (0.94) is worse than 72.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 8.31
Altman-Z 1.6
ROIC/WACC0.56
WACC9.16%
HITI Yearly LT Debt VS Equity VS FCFHITI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

  • HITI has a Current Ratio of 1.37. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
  • HITI has a Current ratio of 1.37. This is in the lower half of the industry: HITI underperforms 73.30% of its industry peers.
  • HITI has a Quick Ratio of 1.37. This is a bad value and indicates that HITI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.70, HITI is doing worse than 85.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 0.7
HITI Yearly Current Assets VS Current LiabilitesHITI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

6

3. Growth

3.1 Past

  • The earnings per share for HITI have decreased strongly by -884.13% in the last year.
  • Looking at the last year, HITI shows a quite strong growth in Revenue. The Revenue has grown by 13.72% in the last year.
  • HITI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 48.14% yearly.
EPS 1Y (TTM)-884.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
Revenue 1Y (TTM)13.72%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%18.61%

3.2 Future

  • The Earnings Per Share is expected to grow by 30.45% on average over the next years. This is a very strong growth
  • HITI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.96% yearly.
EPS Next Y121.5%
EPS Next 2Y60.32%
EPS Next 3Y46.8%
EPS Next 5Y30.45%
Revenue Next Year29.67%
Revenue Next 2Y19.93%
Revenue Next 3Y18.21%
Revenue Next 5Y13.96%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
HITI Yearly Revenue VS EstimatesHITI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
HITI Yearly EPS VS EstimatesHITI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 1 -1

5

4. Valuation

4.1 Price/Earnings Ratio

  • HITI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • HITI is valuated rather expensively with a Price/Forward Earnings ratio of 24.09.
  • HITI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HITI is cheaper than 75.92% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of HITI to the average of the S&P500 Index (27.77), we can say HITI is valued inline with the index average.
Industry RankSector Rank
PE N/A
Fwd PE 24.09
HITI Price Earnings VS Forward Price EarningsHITI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

  • HITI's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. HITI is cheaper than 90.58% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, HITI is valued cheaper than 84.82% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.2
EV/EBITDA 8.42
HITI Per share dataHITI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • HITI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as HITI's earnings are expected to grow with 46.80% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y60.32%
EPS Next 3Y46.8%

0

5. Dividend

5.1 Amount

  • No dividends for HITI!.
Industry RankSector Rank
Dividend Yield 0%

HIGH TIDE INC

NASDAQ:HITI (2/6/2026, 8:00:01 PM)

After market: 2.38 +0.03 (+1.28%)

2.35

+0.08 (+3.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)01-29
Earnings (Next)03-16
Inst Owners13.66%
Inst Owner Change0.16%
Ins Owners8.85%
Ins Owner ChangeN/A
Market Cap205.04M
Revenue(TTM)593.99M
Net Income(TTM)-50.75M
Analysts80
Price Target5.34 (127.23%)
Short Float %0.35%
Short Ratio0.46
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.04%
Min Revenue beat(2)0.98%
Max Revenue beat(2)1.09%
Revenue beat(4)3
Avg Revenue beat(4)0.55%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.13%
Revenue beat(12)9
Avg Revenue beat(12)0.97%
Revenue beat(16)13
Avg Revenue beat(16)7.41%
PT rev (1m)0.11%
PT rev (3m)0.78%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-1.49%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)-0.43%
Revenue NQ rev (3m)-0.43%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 24.09
P/S 0.47
P/FCF 21.2
P/OCF 11.74
P/B 3.2
P/tB N/A
EV/EBITDA 8.42
EPS(TTM)-0.45
EYN/A
EPS(NY)0.1
Fwd EY4.15%
FCF(TTM)0.11
FCFY4.72%
OCF(TTM)0.2
OCFY8.52%
SpS4.98
BVpS0.73
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.54%
ROE -57.92%
ROCE 6.54%
ROIC 5.17%
ROICexc 6.4%
ROICexgc 17.98%
OM 2.74%
PM (TTM) N/A
GM 25.99%
FCFM 2.23%
ROA(3y)-11.05%
ROA(5y)-14.75%
ROE(3y)-30.28%
ROE(5y)-32.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y8.85%
ROICexc growth 3YN/A
ROICexc growth 5Y9.97%
OM growth 3YN/A
OM growth 5Y10.73%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.78%
GM growth 5Y-6.82%
F-Score2
Asset Turnover1.7
Health
Industry RankSector Rank
Debt/Equity 0.94
Debt/FCF 8.31
Debt/EBITDA 2.03
Cap/Depr 43.8%
Cap/Sales 1.79%
Interest Coverage 2.21
Cash Conversion 58.77%
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 0.7
Altman-Z 1.6
F-Score2
WACC9.16%
ROIC/WACC0.56
Cap/Depr(3y)33.59%
Cap/Depr(5y)35.25%
Cap/Sales(3y)1.64%
Cap/Sales(5y)2.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-884.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-700%
EPS Next Y121.5%
EPS Next 2Y60.32%
EPS Next 3Y46.8%
EPS Next 5Y30.45%
Revenue 1Y (TTM)13.72%
Revenue growth 3Y18.51%
Revenue growth 5Y48.14%
Sales Q2Q%18.61%
Revenue Next Year29.67%
Revenue Next 2Y19.93%
Revenue Next 3Y18.21%
Revenue Next 5Y13.96%
EBIT growth 1Y6.44%
EBIT growth 3YN/A
EBIT growth 5Y64.03%
EBIT Next Year707.98%
EBIT Next 3Y142.78%
EBIT Next 5Y80.76%
FCF growth 1Y-48.76%
FCF growth 3YN/A
FCF growth 5Y16.8%
OCF growth 1Y-32.86%
OCF growth 3Y74.46%
OCF growth 5Y21.95%

HIGH TIDE INC / HITI FAQ

What is the fundamental rating for HITI stock?

ChartMill assigns a fundamental rating of 4 / 10 to HITI.


What is the valuation status for HITI stock?

ChartMill assigns a valuation rating of 5 / 10 to HIGH TIDE INC (HITI). This can be considered as Fairly Valued.


Can you provide the profitability details for HIGH TIDE INC?

HIGH TIDE INC (HITI) has a profitability rating of 4 / 10.


Can you provide the expected EPS growth for HITI stock?

The Earnings per Share (EPS) of HIGH TIDE INC (HITI) is expected to grow by 121.5% in the next year.